Among the peripheral blood cluster of differentiation CD34(+) cells from patients with MPN, more GLS is expressed in progenitor cells with mutated JAK2 than in progenitor cells with wild-type JAK2 [198]. This evidence concerns the gene JAK2 and myeloproliferative disorder.